Clinical Trials Logo

Clinical Trial Summary

This a prospective, double-blind, sham-controlled, randomized clinical trial to study the effects of remote ischemic preconditioning on contrast-induced acute kidney injury, vascular and renal biomarkers in patients with non-ST elevation myocardial infarction and unstable angina undergoing cardiac catheterization and percutaneous coronary intervention.


Clinical Trial Description

The BRICK study is a prospective, double-blind, sham-controlled, randomized clinical trial in patients with non-ST elevation myocardial infarction and unstable angina undergoing cardiac catheterization and percutaneous coronary intervention who are at high risk for contrast-induced acute kidney injury. The study will investigate the effects of remote ischemic preconditioning before cardiac catheterization on rate of contrast induced acute kidney injury and novel biomarkers of renal injury/protection within 48hrs of cardiac catheterization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03236441
Study type Interventional
Source University of Pittsburgh
Contact
Status Active, not recruiting
Phase N/A
Start date March 6, 2018
Completion date February 28, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05475717 - A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI Phase 2
Completed NCT04666389 - The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases N/A
Recruiting NCT01947335 - IVUS Guidance to Reduce Contrast in Coronary Angioplasty Phase 4
Recruiting NCT04936607 - ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions N/A
Completed NCT01146925 - Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury Phase 2
Withdrawn NCT03526367 - A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI Phase 4
Completed NCT04714736 - DyeVert System and Contrast-induced Acute Kidney Injury N/A
Not yet recruiting NCT03767322 - Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) Phase 2
Not yet recruiting NCT02808845 - Microalbuminuria Predicting CIAKI After CAG N/A